Related Experiment Video
Updated: May 31, 2026
06:11
Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
Published on: May 17, 2024
Maternal diabetes affects cell proliferation in developing rat placenta.
T M T Zorn1, M Zúñiga, E Madrid
1Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Histology and Histopathology
|June 22, 2011
Summary
Diabetic rats show increased placental cell proliferation, particularly in specific regions and later in pregnancy. This abnormal growth may thicken the placental barrier, potentially impacting maternal-fetal exchange.
Area of Science:
- Reproductive biology
- Developmental biology
- Endocrinology
Background:
- Placentation is crucial for embryo development and nutrient exchange.
- Diabetes is known to increase placental size and weight, but underlying mechanisms are unclear.
- Altered cell proliferation in diabetic placentas is hypothesized.
Purpose of the Study:
- To investigate cell proliferation in placental development in a diabetic rat model.
- To compare proliferation rates in different placental regions between diabetic and control rats.
Main Methods:
- Diabetes induced in Wistar rats on day 2 of pregnancy using alloxan.
- Placentas collected on days 14, 17, and 20 postcoitum.
- Ki67 nuclear antigen staining used to quantify proliferating cells in various placental regions.
Main Results:
- Cell proliferation (Ki67 positive cells) decreased over pregnancy in both groups.
- From day 17, diabetic placentas showed higher proliferation in labyrinth and spongiotrophoblast regions.
- Significant increases in proliferating cells were observed in specific placental regions and developmental stages in diabetic rats.
Conclusions:
- Diabetic rat placentas exhibit significantly higher cell proliferation in defined regions and stages.
- Increased placental cell proliferation may lead to a thicker placental barrier.
- This thickening could potentially disrupt normal maternal-fetal exchange processes.
Related Concept Videos
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.